Research and analysis

MHRA: Business Impact Target

The Medicines and Healthcare products Regulatory Agency (MHRA) assesses its regulatory impact on businesses.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 8 June 2017
• Last updated: 19 December 2022 — See all updates

Documents

MHRA NQRP Summary 2021/22

MS Word Document, 67.3 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MHRA NQRP Summary 2020/21

MS Word Document, 17.8 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MHRA NQRP Summary 2019/20

MS Word Document, 21.3 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MHRA NQRP Summary 2018/19

PDF, 81.4 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MHRA NQRP Summary 2017/18

PDF, 93.9 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MHRA QRP Summary 2016/17

PDF, 4.39 MB, 9 pages

MHRA NQRP Summary 2016/17

PDF, 297 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The business impact target (BIT) is a cross-government target for the reduction of regulation on business.

Under the BIT, MHRA assesses the financial impacts on business of qualifying regulatory provisions (QRPs). QRPs are changes to regulatory practices that are described in a written ministerial statement. We assess the impacts of these changes through BIT assessments.

Any measure that falls within the +/-£5 million de minimis threshold will be out of scope of the BIT, and written up in the Non-Qualifying Regulatory provision (NQRP) summary template.

Between 13 December 2019 – 16 December 2020, there were no measures that came into force above the +/-£5m de minimis threshold; summaries of the MHRA’s NQRPs are available further above.

Published 8 June 2017
Last updated 19 December 2022 + show all updates

1. 19 December 2022

   Added 'MHRA NQRP Summary 2021/22'

2. 20 December 2021

   Added MHRA NQRP Summary 2020/21

3. 27 November 2020

   Added MHRA NQRP Summary 2019/20

4. 2 July 2019

   MHRA Non-Qualifying Regulatory provision (NQRP) Business Impact Target for 2018/19 added to the page.

5. 3 July 2018

   Merged 2016/17 documents and minor re-wording to the text describing the documents available.

6. 2 July 2018

   Added NQRP Summary for 2017/18. Also added new information about no new measures coming into force between June 2017 and June 2018.

7. 17 August 2017

   Updated MHRA NQRP Year 2 summary

8. 10 July 2017

   Added three validated RPC opinions.

9. 8 June 2017

   First published.